MetaCap

Sanofi ADS (SNY)

NASDAQ: SNYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

46.52+0.46 (+1.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SNY stock chart

Technical analysis

Key statistics

All statistics
Market cap
$111.70B
Dividend yield
5.20% ($0.00)
Ex-dividend date
May 4, 2026
52-week range
39.07 – 50.61
Day range
46.45 – 46.98
Volume / Avg
4.29M / 3.41M
Beta
—
Next earnings
Jan 28, 2027

52-week range

$39.07$50.61

SNY stock today

On Nov 20, SNY ended the session at $46.52, adding $0.46 (1.00%), versus the S&P 500's 3.70% decline. At this level, SNY sits in the middle of its 52-week range of $39.07 to $50.61: 8.1% below the high, set on Nov 25, 2025 and 19.1% above the low. SNY is down 4.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 6.3%.

At 23.1x trailing earnings, Sanofi trades above the peer-group median of 20.4x. Its forward P/E of 8.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Sanofi's next earnings report is expected on Jan 28, 2027.

Summary generated from market data by MetaCap's automated system. Methodology

About Sanofi

Company profile

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Ms. Belen Garijo Lopez M.D.
Headquarters
Paris
Employees
74,846
Website
sanofi.com

Analyst forecast

Forecast

Consensus (11 analysts)

buy

Avg. price target

$54.92+18.06%

  • Strong buy 2
  • Buy 4
  • Hold 5
  • Sell 0
  • Strong sell 0

Target range

Low $45.00High $63.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Jan 28, 2027
Last reported (Sep/2026)
Oct 30, 2026
EPS actual vs est.
$1.70 vs $1.63
Surprise
+4.29%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$2.42
Ex-dividend date
May 4, 2026

SNY news

All SNY news

Sanofi peers

Health Care sector
SNY peer companies
CompanyPrice% ChgMarket capCompare
BMYBristol-Myers Squibb Company58.80+0.79%$120.19Bvs SNY
GSKGSK plc ADR47.76-0.13%$95.73Bvs SNY
REGNRegeneron Pharmaceuticals Inc.920.69-0.19%$95.24Bvs SNY
VRTXVertex Pharmaceuticals Incorporated515.02-1.08%$130.58Bvs SNY
TAKTakeda Pharmaceutical Company Limited ADR21.77+1.68%$69.55Bvs SNY
PFEPfizer Inc.27.40-0.51%$156.18Bvs SNY
NVONovo Nordisk A/S37.82-2.70%$166.69Bvs SNY
ABTAbbott Laboratories103.00-0.84%$178.39Bvs SNY

Indexes, lists and sector

Sanofi stock FAQ

What is Sanofi's stock price today?

SNY last traded at $46.52 as of Nov 20, 4:00 PM EST, up 1.00% on the day. Prices are delayed at least 15 minutes.

Does Sanofi pay a dividend?

Yes. Sanofi pays $0.00 per share annually, a 5.20% yield. The most recent dividend of $2.42 had an ex-dividend date of May 4, 2026.

When is Sanofi's next earnings date?

Sanofi is expected to report earnings on Thursday, January 28, 2027.

What is SNY's P/E ratio?

SNY trades at a trailing P/E ratio of 23.14 and a forward P/E of 8.57, compared with a median of 20.4 for its closest peers.

Who is Sanofi's CEO?

Ms. Belen Garijo Lopez M.D. is the chief executive officer of Sanofi ADS, which has about 74,846 employees.

What is the SNY 52-week high?

The 52-week high for SNY is $50.61 and the 52-week low is $39.07. The stock is currently 8.1% below its high.

Compare SNY